N-Acetylneuraminic Acid clinical trials
Also written UX001.
How each study uses N-Acetylneuraminic Acid is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the N-Acetylneuraminic Acid studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2025 | 1 |
Who runs them
Industry 5 · Other 1
Ultragenyx Pharmaceutical Inc (5) · Xiaolong Li (1)
Studies
Open first, then newest update. How each study uses N-Acetylneuraminic Acid is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 6
- A Study on the Modulation of Gut Microbiota by Oral Sialic Acid in Healthy SubjectsRecruitingNot applicableXiaolong LiNCT07162662Written as Oral Sialic acidHow we know
- Study to Evaluate the Safety and Efficacy of Aceneuramic Acid Extended-Release (Ace-ER) Tablets in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)TerminatedPhase 3Ultragenyx Pharmaceutical IncNCT02736188Written as Aceneuramic Acid Extended-Release TabletsHow we know
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Sialic Acid in Patients With Glucosamine (UDP-N-acetyl)-2-epimerase Myopathy (GNEM) or Hereditary Inclusion Body Myopathy (HIBM)CompletedPhase 3Ultragenyx Pharmaceutical IncNCT02377921Written as aceneuramic acid extended-release (Ace-ER)How we know
- A Study to Evaluate the Safety of Aceneuramic Acid Extended Release (Ace-ER; UX001) Tablets in Glucosamine (UDP-N-acetyl)-2-Epimerase (GNE) Myopathy (GNEM) (Also Known as Hereditary Inclusion Body Myopathy [HIBM]) Patients With Severe Ambulatory ImpairmentTerminatedPhase 2Ultragenyx Pharmaceutical IncNCT02731690Written as Aceneuramic Acid Extended-ReleaseHow we know
- A Phase 2 Study to Evaluate the Dose and Pharmacodynamic Efficacy of Sialic Acid-Extended Release (SA-ER) Tablets in Patients With GNE Myopathy or Hereditary Inclusion Body MyopathyCompletedPhase 2Ultragenyx Pharmaceutical IncNCT01517880Written as Sialic Acid Extended Release (SA-ER)How we know
- Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)CompletedPhase 1Ultragenyx Pharmaceutical IncNCT01359319Written as Sialic Acid Extended Release (SA-ER) TabletsHow we know
Codes
What other systems call N-Acetylneuraminic Acid · ClinicalTrials.gg INT008664
- MeSH (NLM) D019158N-Acetylneuraminic AcidConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) GZP2782OP0ACENEURAMIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 2613558One source FDA
- Wikidata Q105593111N-acetylneuraminic acid (open form)Confirmed FDA, NLM, Wikidata
- DrugBank DB11797One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019158 | N-Acetylneuraminic Acid | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | GZP2782OP0 | ACENEURAMIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 2613558 | — | One source FDA |
| Wikidata | Q105593111 | N-acetylneuraminic acid (open form) | Confirmed FDA, NLM, Wikidata |
| DrugBank | DB11797 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.